Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Strengthens Scientific Team by Adding Dr. Brian Mueller as Director of Chemistry and Secures Exclusive Ownership of Iodine Extraction Technology
Voyageur Pharmaceuticals has acquired 100% ownership of the 'Mueller Process', a proprietary iodine extraction technology, and appointed Dr. Brian Mueller as Director of Chemistry. Initial bench-scale testing showed a 90% yield from brine to technical grade iodine, supporting the company's strategy to produce iodine contrast media domestically.